Treatment
Efanesoctocog alfa clinical trials
We’re tracking 5 recruiting studies that include Efanesoctocog alfa, each written for real people, not researchers, below.
Recruiting studies
- NCT06940830RecruitingPhase 4
Long-term joint health study with efanesoctocog alfa
This study checks how well efanesoctocog alfa (a preventive factor VIII treatment) protects your joints over time in people with hemophilia A. It involves regular checkups, joint assessments, and tracking of any bleeding episodes.
ZagrebAges Any age - NCT06716814RecruitingPhase 3
Continuing efanesoctocog alfa after earlier trial
This study provides continued access to the clotting factor treatment efanesoctocog alfa for people who have already been getting it in a previous trial. It helps ensure you can keep using the medicine if it is working for you.
PlovdivAges 6 years+ - NCT06941870RecruitingPhase 4
Efanesoctocog Alfa Preventative Treatment for Hemophilia A with Joint Thickening
This study tests a new preventive treatment (efanesoctocog alfa) for people with hemophilia A who have joint lining thickening. The goal is to see if it helps protect joints.
Los Angeles, CaliforniaAges 12 years+ - NCT06684314Recruiting
Efanesoctocog alfa for long-term joint health in hemophilia A
This study tests how well a new factor VIII medicine, efanesoctocog alfa, protects your joints over time. It's for people with moderate or severe hemophilia A who are just starting this treatment.
ChanghuaAges Any age - NCT07723560Recruiting
Surgery study for hemophilia A patients using Altuvoct
This study looks at how people with hemophilia A do when they have surgery while using the medicine Altuvoct (efanesoctocog alfa). It helps doctors learn more about surgical practices for this condition.
BronAges Any age
What Efanesoctocog alfa is being studied for
Conditions with recruiting Efanesoctocog alfa studies.
Common questions
- Are there clinical trials studying Efanesoctocog alfa?
- Yes. Clin2 currently lists 5 recruiting studies that include Efanesoctocog alfa, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Efanesoctocog alfa trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Efanesoctocog alfa an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Efanesoctocog alfa or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.